Free tool
Stocks listed on Stockholm
We cover 46 companies listed on Stockholm. The median market value in the group is $812.84M. Across the group, the median move over the past trading day is +0.66%. 70% of the 46 with a 200-day average trade above it. Price change over the past year runs from −39.4% to +45.0% across the middle 80 percent of the group, with a median of −7.7%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
46 of 928 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| STIL.ST | Stille AB | 225.00 SEK | −5.06% | +16.58% | −4.26% |
| CARA.ST | Carasent AB (publ) | 25.25 SEK | +1.00% | −5.78% | −10.62% |
| FLERIE.ST | Flerie AB (publ) | 19.25 SEK | −3.02% | −40.94% | −48.05% |
| SANION.ST | Saniona AB (publ) | 11.83 SEK | −15.32% | −43.93% | −12.37% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% |
| CRNO-B.ST | Cereno Scientific AB (publ) | 4.71 SEK | +0.13% | −32.04% | −53.59% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| GENO.ST | Genovis AB (publ.) | 20.15 SEK | +2.81% | −7.36% | −16.91% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% |
| CRAD-B.ST | C-Rad AB (publ) | 35.30 SEK | −4.08% | +11.00% | +6.49% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | 6.10 SEK | −17.57% | +7.02% | −0.81% |
| SYNACT.ST | SynAct Pharma AB | 19.66 SEK | +12.99% | −12.43% | +10.82% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.